SIBO Breath Test: Drugs That Distort Results, Normal Ranges, and What Your Numbers Mean

What the SIBO Breath Test Actually Measures

The SIBO breath test is a non-invasive tool that detects excess bacteria in the small intestine by tracking fermentation gases. After you drink a measured dose of a fermentable sugar, any bacteria present in the small bowel ferment that substrate and produce H2 and CH4. Those gases cross the gut wall, enter the bloodstream, and are exhaled through the lungs, where a sensor captures them in parts per million (ppm).

The Two Gas Channels

Hydrogen comes primarily from bacterial fermentation of carbohydrates. Methane is produced by a separate group of organisms called methanogenic archaea, most commonly Methanobrevibacter smithii. A 2020 consensus statement from the American College of Gastroenterology noted that measuring both gases simultaneously is necessary because roughly 30-35% of SIBO-positive patients produce predominant methane rather than hydrogen, and a single-gas device will miss them. [1]

Hydrogen sulfide is a third fermentation gas that some newer devices capture. Standard clinical testing does not yet include it routinely, but research protocols at several academic centers are evaluating its role in diarrhea-predominant irritable bowel syndrome overlap. [2]

The Two Substrates in Common Use

Lactulose is a non-absorbable disaccharide. Because it is never absorbed in the small bowel, it reaches the colon in every patient, which means the colon's own microbiome always generates a second large gas peak. Reading a lactulose test requires distinguishing a small-bowel peak (early rise before 90 minutes) from the colonic peak. This timing dependency makes lactulose more sensitive but less specific. A 2017 systematic review in Alimentary Pharmacology and Therapeutics (N=1,278) reported lactulose sensitivity at 68% and specificity at 70% against jejunal aspirate culture. [3]

Glucose is absorbed completely in the proximal small bowel in healthy people, so any gas produced signals bacteria in that segment. Glucose is more specific (approximately 83%) but misses bacteria located in the distal small intestine where the substrate is already gone. [3]

Your clinician's choice of substrate depends on your suspected anatomy and symptom pattern. Most U.S. Telehealth and gastroenterology protocols use lactulose as the default.

Normal SIBO Breath Test Ranges

Normal values depend on the gas, the substrate, and the time point. There is no single universally adopted range, but the 2017 North American Consensus defines the most widely used thresholds. [4]

Hydrogen (H2) Reference Values

• Baseline (fasting, time 0): <20 ppm is normal. A fasting baseline above 20 ppm may indicate inadequate prep, recent high-fiber intake, or a positive test without even needing the substrate challenge.
• Post-challenge rise: A rise of ≥20 ppm above baseline at any point during the first 90 minutes of a lactulose test, or within 60 minutes on a glucose test, meets the consensus threshold for a positive result. [4]
• Colonic peak on lactulose: A large secondary rise after 100-120 minutes is expected. That secondary peak is the colon responding to substrate arrival, not SIBO.

Methane (CH4) Reference Values

• Any time point ≥10 ppm is considered positive under the 2017 North American Consensus regardless of timing or rise from baseline. [4]
• Some labs apply a stricter threshold of ≥12 ppm to reduce false positives in patients who have eaten high-fiber food despite prep instructions.

Hydrogen Sulfide (H2S) Reference Values

No validated clinical threshold exists as of 2025. Research protocols use any detectable elevation above 1-2 ppm as a signal worthy of further evaluation. [2]

Drugs That Falsely Lower the SIBO Breath Test

This is where the most clinically consequential errors occur. A falsely negative result means a patient with real SIBO gets told they are fine, remains untreated, and continues experiencing malabsorption, bloating, and nutrient deficiencies.

Antibiotics: The Biggest Confounder

Any antibiotic taken within approximately four weeks before testing can suppress the bacterial populations responsible for gas production, producing a falsely negative result. This applies regardless of the antibiotic's intended target: a course of amoxicillin prescribed for sinusitis two weeks before a scheduled SIBO test will blunt H2 readings just as effectively as rifaximin prescribed specifically for SIBO. [5]

The 2017 North American Consensus explicitly states: "Antibiotics should be discontinued at least 4 weeks before breath testing." [4]

Specific antibiotics documented to suppress breath test readings include:

• Rifaximin (used to treat SIBO itself; renders follow-up testing unreliable for at least 4 weeks post-treatment)
• Metronidazole and tinidazole
• Neomycin (frequently co-prescribed with rifaximin for methane-dominant SIBO)
• Fluoroquinolones (ciprofloxacin, levofloxacin)
• Tetracyclines (doxycycline, minocycline)
• Amoxicillin-clavulanate

A post-treatment breath test ordered less than four weeks after rifaximin completion is not interpretable. Retesting at the four-week mark is the minimum accepted washout. [5]

Probiotics and Certain Dietary Supplements

Probiotic supplements containing Lactobacillus or Bifidobacterium species can transiently alter fermentation kinetics. The 2017 consensus recommends stopping probiotics at least 1-2 weeks before testing. [4] The evidence for the magnitude of this effect is limited, but the precaution is standard.

Activated charcoal, sold over-the-counter for bloating, adsorbs gases in the gut and will reduce measured exhaled H2. Stop it at least 48 hours before testing.

Bowel Prep Agents and Laxatives

This is counterintuitive. A complete bowel prep (polyethylene glycol such as MiraLAX, taken in a full colonoscopy-prep dose) clears the colonic microbiome temporarily, which reduces background colonic gas and can make a true early small-bowel peak harder to distinguish. Standard clinical guidance is to avoid laxatives for at least 24 hours before testing. [4]

Proton Pump Inhibitors (PPIs)

PPIs such as omeprazole, pantoprazole, and esomeprazole raise gastric pH, which theoretically allows more oral bacteria to survive transit to the small bowel and increases baseline bacterial load. The net effect on breath test numbers is context-dependent: chronic PPI use may actually produce false positives (see below), but acute PPI suppression of gastric motility can also alter the rate of substrate delivery to the small bowel, changing the timing of the gas curve in ways that complicate interpretation. [6]

The practical guidance from most gastroenterology programs is to hold PPIs for two weeks before testing when clinically safe, after discussion with the prescribing physician.

Drugs That Falsely Raise the SIBO Breath Test

A falsely positive result places a patient on unnecessary antibiotics, which carries its own risks including Clostridioides difficile infection and microbiome disruption.

Proton Pump Inhibitors: The False-Positive Driver

Chronic PPI use is the most extensively documented pharmacologic cause of false-positive SIBO breath tests. A 2021 meta-analysis in Gut (21 studies, N=7,655) found that PPI users had a significantly higher odds of a positive SIBO breath test compared with non-users (OR 1.71, 95% CI 1.20-2.43, P<0.001). [6] The mechanism involves reduced gastric acid allowing greater bacterial colonization of the proximal small bowel, but a competing hypothesis argues the positive tests in PPI users reflect real bacterial overgrowth rather than assay artifact. Either way, clinical interpretation of a positive result in a patient on long-term PPIs requires additional context.

Metformin

Metformin alters the gut microbiome composition and increases intestinal transit time through mechanisms that remain under investigation. Two studies have reported elevated fasting H2 baseline values in type 2 diabetes patients on metformin compared to matched controls, with one observational study (N=82) showing mean fasting H2 of 18.4 ppm in metformin users versus 8.1 ppm in non-users. [7] A baseline above 20 ppm invalidates the standard positivity criteria because you cannot calculate a meaningful rise from an already-elevated starting point. This does not mean metformin-treated patients cannot be tested; it means the clinician must account for the elevated baseline in interpretation.

Lactulose-Containing Laxatives

Lactulose syrup is sold as a prescription laxative (brand name Kristalose, Enulose). A patient who takes lactulose as a constipation treatment and continues it before a lactulose breath test is essentially pre-loading the substrate, which saturates colonic fermentation and produces elevated readings that do not reflect true small-bowel bacterial activity. Stop lactulose laxatives at least one week before testing. [4]

Opioids and Motility-Slowing Agents

Opioids (oxycodone, hydrocodone, codeine, tramadol) slow gastrointestinal transit dramatically through mu-opioid receptor activation in the gut. Delayed transit means the lactulose substrate spends more time in the small bowel, giving bacteria longer contact time and producing a higher peak. A 2018 study in Neurogastroenterology and Motility found that patients on chronic opioid therapy had significantly prolonged orocecal transit times, which shifted the expected colonic gas peak earlier in the breath test time series and mimicked the pattern of SIBO on lactulose testing. [8] On a glucose breath test, this effect is less pronounced because glucose is absorbed before reaching the distal small bowel.

Other motility-slowing drugs that carry a similar risk: tricyclic antidepressants (amitriptyline, nortriptyline), anticholinergic agents (dicyclomine, hyoscyamine), and calcium channel blockers at higher doses.

Colonoscopy Bowel Prep Within the Prior 48-72 Hours

A bowel prep taken within two to three days before a breath test can paradoxically produce high early H2 readings because it irritates the bowel mucosa and accelerates small-bowel transit, moving the substrate to bacteria in the ileum faster than normal. This is rarely a clinical scenario but worth noting if a patient had recent endoscopy.

Other Non-Drug Variables That Distort Results

Drug interactions are the leading cause of distorted readings, but several other pre-test factors deserve attention because they are just as actionable.

Dietary Prep Failures

The standard pre-test diet restricts fermentable carbohydrates for 24 hours before testing: no high-fiber foods, no beans, no dairy, no alcohol, no whole grains. Patients who eat a high-FODMAP meal the night before testing arrive with an already-elevated baseline H2. The prep instructions should be written, not verbal, and confirmed at check-in. [4]

Recent Colonoscopy or Bowel Prep

A colonoscopy prep that clears the colon will transiently eliminate the colonic microbiome. Testing within two weeks of a full bowel prep may yield atypically low colonic peaks, making small-bowel peaks appear proportionally larger by comparison. Waiting at least two weeks post-colonoscopy is standard. [4]

Smoking on the Test Day

Cigarette smoke contains trace hydrogen and carbon monoxide. Smoking within two hours of a breath test can raise baseline readings. Patients should be instructed not to smoke from midnight before the test. [4]

Vigorous Exercise

Acute vigorous exercise increases H2 output through accelerated gut transit and increased breath rate, which changes the kinetics of gas elimination. The 2017 consensus recommends avoiding vigorous exercise on the morning of the test. [4]

How to Interpret a Positive Result in Context

A positive breath test alone is not a diagnosis. The test has documented sensitivity of 54-90% and specificity of 70-85% depending on substrate and criteria applied. [3] That means roughly 1 in 7 positive results may be a false positive even in an optimally prepared patient.

Correlating With Symptoms

The American College of Gastroenterology's 2020 clinical guideline states: "A positive breath test should be interpreted in the context of clinical symptoms, and treatment decisions should not be based on breath test results alone." [1] Symptoms that strengthen the clinical case for true SIBO include postprandial bloating within 30-90 minutes of eating, unexplained fat malabsorption, vitamin B12 deficiency with normal dietary intake, and iron-deficiency anemia without a bleeding source.

The Role of Jejunal Aspirate Culture

The technical gold standard remains quantitative culture of jejunal aspirate with a threshold of ≥10³ CFU/mL (or in some labs ≥10&sup5; CFU/mL for coliforms). [9] This requires upper endoscopy and is not practical for routine use, but it remains the reference standard against which breath test performance is measured in clinical trials.

When to Retest

Retest a negative result in a patient with strong clinical symptoms if any of the confounding drugs listed above were present during the index test, or if the dietary prep was not followed. A repeat test after proper washout changes the result in a meaningful minority of cases.

Standard SIBO Treatment: What Happens After a Positive Test

Understanding treatment is relevant here because the choice of antibiotic creates a washout obligation for any subsequent confirmatory testing.

Rifaximin for Hydrogen-Dominant SIBO

Rifaximin 550 mg three times daily for 14 days is the most studied regimen for non-constipation SIBO. The TARGET-1 and TARGET-2 trials (N=1,258 combined) demonstrated adequate relief of bloating in 40% of patients treated with rifaximin versus 30% placebo (P<0.001). [10] Because rifaximin is minimally absorbed systemically, it carries a low risk of systemic side effects, though its gut-level action is potent enough to suppress H2 production on a follow-up breath test for at least four weeks.

Rifaximin Plus Neomycin for Methane-Dominant SIBO

Methane-dominant SIBO (intestinal methanogen overgrowth, or IMO) responds poorly to rifaximin alone. A 2014 study in Digestive Diseases and Sciences (N=67) found that the combination of rifaximin 550 mg twice daily plus neomycin 500 mg twice daily for 14 days produced a significantly higher methane normalization rate (85%) than rifaximin alone (34%, P<0.001). [11] Both drugs suppress breath test gases; the four-week washout applies to both.